Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis.
Hendrikse CSE, Theelen PMM, van der Ploeg P, Westgeest HM, Boere IA, Thijs AMJ, Ottevanger PB, van de Stolpe A, Lambrechts S, Bekkers RLM, Piek JMJ. Hendrikse CSE, et al. Among authors: ottevanger pb. Gynecol Oncol. 2023 Apr;171:83-94. doi: 10.1016/j.ygyno.2023.01.038. Epub 2023 Feb 24. Gynecol Oncol. 2023. PMID: 36841040 Free article. Review.
Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review of literature.
Verheecke M, Halaska MJ, Lok CA, Ottevanger PB, Fruscio R, Dahl-Steffensen K, Kolawa W, Gziri MM, Han SN, Van Calsteren K, Van den Heuvel F, De Vleeschouwer S, Clement PM, Menten J, Amant F; ESGO Task Force ‘Cancer in Pregnancy’. Verheecke M, et al. Among authors: ottevanger pb. Eur J Cancer. 2014 May;50(8):1462-71. doi: 10.1016/j.ejca.2014.02.018. Epub 2014 Mar 14. Eur J Cancer. 2014. PMID: 24636876 Review.
Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting.
Amant F, Halaska MJ, Fumagalli M, Dahl Steffensen K, Lok C, Van Calsteren K, Han SN, Mir O, Fruscio R, Uzan C, Maxwell C, Dekrem J, Strauven G, Mhallem Gziri M, Kesic V, Berveiller P, van den Heuvel F, Ottevanger PB, Vergote I, Lishner M, Morice P, Nulman I; ESGO task force ‘Cancer in Pregnancy’. Amant F, et al. Among authors: ottevanger pb. Int J Gynecol Cancer. 2014 Mar;24(3):394-403. doi: 10.1097/IGC.0000000000000062. Int J Gynecol Cancer. 2014. PMID: 24445819 Review.
[Chemotherapy in metastasized breast cancer].
Beex LV, Tjan-Heijnen VC, Ottevanger PB. Beex LV, et al. Among authors: ottevanger pb. Ned Tijdschr Geneeskd. 1999 Jan 2;143(1):59-60. Ned Tijdschr Geneeskd. 1999. PMID: 10086103 Dutch. No abstract available.
EORTC-GCG process quality indicators for ovarian cancer surgery.
Verleye L, Ottevanger PB, van der Graaf W, Reed NS, Vergote I; Gynaecological Cancer Group (GCG) of European Organisation for Research and Treatment of Cancer (EORTC). Verleye L, et al. Among authors: ottevanger pb. Eur J Cancer. 2009 Mar;45(4):517-26. doi: 10.1016/j.ejca.2008.09.031. Epub 2008 Nov 14. Eur J Cancer. 2009. PMID: 19013789 Review.
Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol.
Creemers JHA, Pawlitzky I, Grosios K, Gileadi U, Middleton MR, Gerritsen WR, Mehra N, Rivoltini L, Walters I, Figdor CG, Ottevanger PB, de Vries IJM. Creemers JHA, et al. Among authors: ottevanger pb. BMJ Open. 2021 Nov 30;11(11):e050725. doi: 10.1136/bmjopen-2021-050725. BMJ Open. 2021. PMID: 34848513 Free PMC article.
Trends in quality of non-Hodgkin's lymphoma care: is it getting better?
Stienen JJ, Ottevanger PB, Wennekes L, van de Schans SA, Dekker HM, van der Maazen RW, van Krieken JH, Blijlevens NM, Hermens RP; PEARL study group. Stienen JJ, et al. Among authors: ottevanger pb. Ann Hematol. 2015 Jul;94(7):1195-203. doi: 10.1007/s00277-015-2340-0. Epub 2015 Mar 15. Ann Hematol. 2015. PMID: 25772630 Free PMC article. Clinical Trial.
Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.
Verleye L, Ottevanger PB, Kristensen GB, Ehlen T, Johnson N, van der Burg ME, Reed NS, Verheijen RH, Gaarenstroom KN, Mosgaard B, Seoane JM, van der Velden J, Lotocki R, van der Graaf W, Penninckx B, Coens C, Stuart G, Vergote I. Verleye L, et al. Among authors: ottevanger pb. Eur J Cancer. 2011 Jan;47(1):57-64. doi: 10.1016/j.ejca.2010.08.008. Epub 2010 Sep 16. Eur J Cancer. 2011. PMID: 20850296 Clinical Trial.
145 results